SCHEMBL20127448

SCHEMBL20127448

c1ccc2c(-c3c4ccccc4c(-c4cc5ccc6ccccc6c5c5ccccc45)c4ccccc34)c3oc4ccccc4c3cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
SOS1 Q07889 1/20 0.36
AHR P35869 5/20 0.36
NQO2 P16083 2/20 0.36
NQO1 P15559 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HIF1A Q16665 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP1B1 Q16678 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 2/20 0.33
FYN P06241 2/20 0.33
ERBB2 P04626 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127648 0.92 TDP1 (0.40) L3MBTL1TDP1AHRNQO2HSD17B10
SCHEMBL20127405 0.88 TDP1 (0.41) L3MBTL1TDP1AHRALDH1A1HSD17B10
SCHEMBL10122560 0.88 AHR (0.41) L3MBTL1TDP1SOS1AHRALDH1A1
SCHEMBL24236136 0.87 AHR (0.36) L3MBTL1SOS1AHRALDH1A1HIF1A
SCHEMBL20127437 0.87 SOS1 (0.39) L3MBTL1TDP1SOS1AHRNQO2
SCHEMBL20127444 0.86 AHR (0.38) L3MBTL1TDP1SOS1AHRALDH1A1
SCHEMBL10122689 0.84 AHR (0.47) L3MBTL1TDP1AHRNQO1ALDH1A1
SCHEMBL20127689 0.84 L3MBTL1 (0.41) L3MBTL1TDP1AHRALDH1A1HSD17B10
SCHEMBL13010573 0.84 ALOX5 (0.46) L3MBTL1TDP1AHRALDH1A1HIF1A
SCHEMBL10122563 0.83 ALOX5 (0.41) SOS1AHRALDH1A1HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 L3MBTL1 1670/4885TDP1 3427/4885SOS1 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.